Universitätsklinikum Würzburg 

ZIM (Zentrum Innere Medizin)
Haus A3/A4 

Oberdürrbacherstr. 6

97080 Würzburg


Chlorhexidine containing IV securement dressings for the prevention of central venous catheter-related bloodstream infections in neutropenic patients: a randomized trial (COAT) Identifier: NCT01544686

CUBIST: A Randomized, Double-Blinded, Active-Controlled Study of CB-183,315 in Patients with Clostridium difficile Associated Diarrhea Identifier: NCT01597505
EudraCT No.: 2012-000252-34

Maribavir: A Phase 2, randomized, dose-ranging study to assess the safety and anti-Cytomegalovirus (CMV) activity of Maribavir versus Valganciclovir for treatment of CMV infections in transplant recipients who do not have CMV organ disease
EudraCT No.: 2010-024247-32

A phase III, randomised, observer-blind, placebo controlled, multicentre, clinical trial to assess the prophylactic efficacy, safety, and immunogenicity of GSK Biologicals’ herpes zoster gE/AS01B vaccine when administered intramuscularly on a two dose schedule to adult autologous haematopoietic stem cell transplant (HCT) recipients.
EudraCT No.: 2012-000138-20 Identifier: NCT01610414

A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of a Single Infusion of MK-6072 (Monoclonal Antibody to Clostridium difficile toxin B) and MK-3415A (Human Monoclonal Antibody to Clostridium difficile toxin A and B) in Patients Receiving Antibiotic Therapy for Clostridium difficile Infection
EudraCT No.: 2011-004994-94 Identifier: NCT01513239